The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings

PLoS Med. 2019 May 29;16(5):e1002820. doi: 10.1371/journal.pmed.1002820. eCollection 2019 May.

Abstract

In a Policy Forum, Peter Ehrenkranz and colleagues discuss the contribution of CD4 and viral load testing to outcomes for people with HIV in low- and middle-income countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • CD4 Lymphocyte Count*
  • Developing Countries* / economics
  • Global Health* / economics
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV* / drug effects
  • HIV* / growth & development
  • HIV* / immunology
  • Health Care Costs
  • Health Services Accessibility
  • Humans
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • Viral Load*

Substances

  • Anti-HIV Agents